Richard Hsi, MD
Radiation Oncology · Seattle, WANPI 1992815971
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 78.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $8,606 and has fallen 77.6% since, to $1,930 in 2025. Among radiation oncology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $214.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$14K
- Palette Life Sciences, Inc.$989
- Bioprotect Medical, Inc.$876
- Theragenics Corporation$645
- Isoray, Inc$455
- Telix Pharmaceuticals$325
- plus $526 from 4 others
What the payments were for
- Consulting fees$5,85033%
- Speaking & faculty fees$3,72521%
- Travel & lodging$1,90511%
- Food & beverage$6,08935%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 50 | $13,752 |
| Palette Life Sciences, Inc. | 8 | $989 |
| Bioprotect Medical, Inc. | 5 | $876 |
| Theragenics Corporation | 2 | $645 |
| Isoray, Inc | 6 | $455 |
| Telix Pharmaceuticals | 4 | $325 |
| GT Medical Technologies, Inc | 3 | $206 |
| Varian Medical Systems, Inc. | 2 | $206 |
| Blue Earth Diagnostics | 1 | $90 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SpaceOAR System$6,256
- SPACEOAR$2,400
- SpaceOAR VUE System - 10mL$1,634
- SPACEOAR VUE$1,217
- BIOPROTECT BALLOON IMPLANT SYSTEM$745
- GENERAL - THERAPIES$410
- ILLUCCIX$246
- GENERAL VASCULAR ACCESS$225
- GENERAL ONCOLOGY$137
- Brachytherapy Source$129
- Treatment Planning Systems$110
How this compares
$17,569 in reported general payments places this provider in the 95th percentile of 168 radiation oncology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 106 | $1,531 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 77 | $194 |
| Ciprofloxacin Hcl | 22 | $89 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Seattle
- Vivek MehtaSeattle$120K
- Christopher LoiselleSeattle$63K
- Ramesh RenganSeattle$57K
- Jing ZengSeattle$37K
- Omar MianSeattle$22K
- Michael FolkertSeattle$11K
- Kent WallnerSeattle$9K
- Robert MeierSeattle$8K
- Shannon FoghSeattle$8K
- Vonetta WilliamsSeattle$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.